Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Insertional mutagenesis of ricin A chain: a novel route to an anti-ricin vaccine

Tools
- Tools
+ Tools

UNSPECIFIED (2004) Insertional mutagenesis of ricin A chain: a novel route to an anti-ricin vaccine. VACCINE, 22 (21-22). pp. 2800-2805. doi:10.1016/j.vaccine.2004.01.024

Research output not available from this repository, contact author.
Official URL: http://dx.doi.org/10.1016/j.vaccine.2004.01.024

Request Changes to record.

Abstract

The insertion of a specific 25-residue internal peptide into ricin toxin A chain (RTA) reduced the catalytic activity of this protein similar to300-fold. Directed proteolytic cleavage of the peptide insert essentially restored catalytic activity of the resulting two peptide A chain to normal levels. Ricin holotoxin containing unprocessed mutant A chain was not toxic to cultured mammalian cells, due to enhanced proteasomal degradation, nor was it toxic when injected into rats at a concentration that is lethal in the case of native ricin. Rats treated in this way were completely resistant to native ricin when subsequently challenged with a potentially lethal dose of the toxin. These ricin-resistant animals had a significant anti-ricin antibody titer, indicating that this approach has potential for developing an effective vaccine against this toxin. (C) 2004 Elsevier Ltd. All rights reserved.

Item Type: Journal Article
Subjects: Q Science > QR Microbiology > QR180 Immunology
R Medicine
Journal or Publication Title: VACCINE
Publisher: ELSEVIER SCI LTD
ISSN: 0264-410X
Official Date: 29 July 2004
Dates:
DateEvent
29 July 2004UNSPECIFIED
Volume: 22
Number: 21-22
Number of Pages: 6
Page Range: pp. 2800-2805
DOI: 10.1016/j.vaccine.2004.01.024
Publication Status: Published

Data sourced from Thomson Reuters' Web of Knowledge

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item
twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us